127 results on '"Mullan, Mike"'
Search Results
2. A 3-month-delayed treatment with anatabine improves chronic outcomes in two different models of repetitive mild traumatic brain injury in hTau mice
3. Nilvadipine suppresses inflammation via inhibition of P-SYK and restores spatial memory deficits in a mouse model of repetitive mild TBI
4. sj-pdf-1-jcb-10.1177_0271678X20954015 - Supplemental material for Impairment of cerebrovascular reactivity in response to hypercapnic challenge in a mouse model of repetitive mild traumatic brain injury
5. sj-pdf-4-jcb-10.1177_0271678X20954015 - Supplemental material for Impairment of cerebrovascular reactivity in response to hypercapnic challenge in a mouse model of repetitive mild traumatic brain injury
6. sj-pdf-2-jcb-10.1177_0271678X20954015 - Supplemental material for Impairment of cerebrovascular reactivity in response to hypercapnic challenge in a mouse model of repetitive mild traumatic brain injury
7. sj-pdf-5-jcb-10.1177_0271678X20954015 - Supplemental material for Impairment of cerebrovascular reactivity in response to hypercapnic challenge in a mouse model of repetitive mild traumatic brain injury
8. sj-pdf-3-jcb-10.1177_0271678X20954015 - Supplemental material for Impairment of cerebrovascular reactivity in response to hypercapnic challenge in a mouse model of repetitive mild traumatic brain injury
9. T-cells in alzheimer’s disease
10. Repetitive Mild Traumatic Brain Injury Augments Tau Pathology and Glial Activation in Aged hTau Mice
11. CD40 is expressed and functional on neuronal cells
12. Impairment of cerebrovascular reactivity in response to hypercapnic challenge in a mouse model of repetitive mild traumatic brain injury
13. Genetic and molecular advances in Alzheimer's disease
14. Aβ Vasoactivity in Vivo
15. Impairment of cerebrovascular reactivity in response to hypercapnic challenge in a mouse model of repetitive mild traumatic brain injury.
16. CD40–CD40L interaction in Alzheimer's disease
17. Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's β-amyloid 1–42
18. The opioid receptor system and alcoholism: a genetic perspective
19. Treatment With Nilvadipine Mitigates Inflammatory Pathology and Improves Spatial Memory in Aged hTau Mice After Repetitive Mild TBI
20. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer’s Disease Dementia in Individuals With Mild Cognitive Impairment
21. Familial Alzheimer's Disease: Second Gene Locus Located: Markers For Cases Of Early Onset Familial Disease May Soon Be Available
22. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene
23. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
24. Rapid and Cost-effective Purification of Endo-Lys-N from Maitake (Grifola Frondosa) Mushrooms for Proteomics Applications
25. In search of the soluble
26. Genomic regulation after CD40 stimulation in microglia: Relevance to Alzheimer's disease
27. Anti-angiogenic activity of the mutant Dutch Aβ peptide on human brain microvascular endothelial cells
28. Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's β-amyloid1–42
29. p35/Cdk5 pathway mediates soluble amyloid‐β peptide‐induced tau phosphorylation in vitro
30. The microtubule associated protein Tau gene and Alzheimer's disease – an association study and meta-analysis
31. CD45 Opposes β-Amyloid Peptide-Induced Microglial Activation via Inhibition of p44/42 Mitogen-Activated Protein Kinase
32. No association between the NOS3 codon 298 polymorphism and Alzheimer's disease in a sample from the United States
33. Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease
34. The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sample
35. No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples
36. Familial Alzheimer's disease: second gene locus located
37. Soluble Alzheimers β-amyloid constricts the cerebral vasculature in vivo
38. Alzheimer's β‐amyloid vasoactivity: identification of a novel β‐amyloid conformational intermediate
39. Characteristics of thein VitroVasoactivity of β-Amyloid Peptides
40. β‐amyloid Peptides and Enhancement of Vasoconstriction by Endothelin‐1
41. The Vasoactivity of A? Peptides
42. Superoxide free radical and intracellular calcium mediate Aβ1–42 induced endothelial toxicity
43. Genetic Approaches to Mental Disorders
44. Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative
45. Technical Feasibility of Genetic Testing for Alzheimerʼs Disease
46. Screening for the APP codon mutations in Alzheimer's disease
47. A locus for familial early–onset Alzhelmer's disease on the long arm of chromosome 14, proximal to the α1–antichymotrypsin gene
48. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid
49. Alzheimer's — a correction
50. Screening for mutations in the open reading frame and promoter of the β-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP717 Val→lle
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.